cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Castle Biosciences Inc
4 own
2 watching
Current Price
$22.73
$1.68
(7.98%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
606.58M
52-Week High
52-Week High
36.095
52-Week Low
52-Week Low
15.58
Average Volume
Average Volume
0.23M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization606.58M
icon52-Week High36.095
icon52-Week Low15.58
iconAverage Volume0.23M
iconDividend Yield--
iconP/E Ratio--
What does the Castle Biosciences Inc do?
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient s tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas.
Read More
How much money does Castle Biosciences Inc make?
News & Events about Castle Biosciences Inc.
Business Wire
1month ago
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has teamed up with IMPACT Melanoma, one of the nation's leading non-profit organizations dedicated to melanoma prevention and early detection, as sunscreen...
Ticker Report
1month ago
Castle Biosciences, Inc. (NASDAQ:CSTL Get Rating) insider Derek J. Maetzold sold 969 shares of the businesss stock in a transaction dated Wednesday, April 12th. The shares were sold at an average price of $22.61, for a total value of $21,909.09. Following the sale, the insider now ...
Business Wire
1month ago
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that Derek Maetzold, president and chief executive officer, and Frank Stokes, chief financial officer, are scheduled to present a company overview at the 22nd Annual...
Zolmax
1month ago
Castle Biosciences, Inc. (NASDAQ:CSTL Get Rating) Director Daniel Bradbury sold 10,300 shares of the companys stock in a transaction that occurred on Monday, April 3rd. The stock was sold at an average price of $22.14, for a total value of $228,042.00. Following the sale, the director now directly ...
Business Wire
2 months ago
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today shared new performance data from a novel, multi-center, independent cohort demonstrating how the independent risk-stratification of DecisionDx-SCC (the Companys 40-gene...
Frequently Asked Questions
Frequently Asked Questions
What is Castle Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Castle Biosciences Inc shares?
plus_minus_icon
How can I buy Castle Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Castle Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Castle Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Castle Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Castle Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Castle Biosciences Inc?
plus_minus_icon
What percentage is Castle Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Castle Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$22.73
$1.68
(7.98%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
SOTERA HEALTH CO
SOTERA HEALTH CO
$14.77
$0.58 (4.09 %)
Genetron Holdings Ltd - ADR
Genetron Holdings Ltd - ADR
$0.88
$-0.01 (-1.44 %)
Burning Rock Biotech Ltd
Burning Rock Biotech Ltd
$2.42
$-0.16 (-6.20 %)
MultiPlan Corp
MultiPlan Corp
$1.65
$0.18 (12.24 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
SOTERA HEALTH CO
SOTERA HEALTH CO
$14.77
$0.58 (4.09 %)
Genetron Holdings Ltd - ADR
Genetron Holdings Ltd - ADR
$0.88
$-0.01 (-1.44 %)
Burning Rock Biotech Ltd
Burning Rock Biotech Ltd
$2.42
$-0.16 (-6.20 %)
MultiPlan Corp
MultiPlan Corp
$1.65
$0.18 (12.24 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00